These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37258624)

  • 1. Digital health, digital medicine, and digital therapeutics in cardiology: current evidence and future perspective in Japan.
    Nomura A
    Hypertens Res; 2023 Sep; 46(9):2126-2134. PubMed ID: 37258624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethics of digital therapeutics (DTx).
    Refolo P; Sacchini D; Raimondi C; Spagnolo AG
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6418-6423. PubMed ID: 36196692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital therapeutics in hypertension: How to make sustainable lifestyle changes.
    Chen C; Liu A; Zhang Z; Chen J; Huang H
    J Clin Hypertens (Greenwich); 2024 Oct; 26(10):1125-1132. PubMed ID: 39248244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stakeholders' Perceptions Regarding Digital Therapeutics Reimbursement in South Korea: Qualitative Study.
    Sim B; Ju JH; Kim B; Lee JY
    JMIR Mhealth Uhealth; 2023 Oct; 11():e47407. PubMed ID: 37933414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of digital therapeutics for essential hypertension.
    Nomura A; Tanigawa T; Kario K; Igarashi A
    Hypertens Res; 2022 Oct; 45(10):1538-1548. PubMed ID: 35726085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navigating the future of health care with AI-driven digital therapeutics.
    Vasdev N; Gupta T; Pawar B; Bain A; Tekade RK
    Drug Discov Today; 2024 Sep; 29(9):104110. PubMed ID: 39034025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Success Factors for Scaling Up the Adoption of Digital Therapeutics Towards the Realization of P5 Medicine.
    Prodan A; Deimel L; Ahlqvist J; Birov S; Thiel R; Toivanen M; Kolitsi Z; Kalra D
    Front Med (Lausanne); 2022; 9():854665. PubMed ID: 35492346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital Therapeutics in Hearing Healthcare: Evidence-Based Review.
    Kim N; Nakamura KA
    J Audiol Otol; 2024 Jul; 28(3):159-166. PubMed ID: 38973323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reimbursement of Digital Therapeutics: Future Perspectives in Korea.
    Ju JH; Sim B; Lee J; Lee JY
    Korean Circ J; 2022 Apr; 52(4):265-279. PubMed ID: 35388995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of the key drivers of the Japanese digital therapeutics patents: A cross-sectional study.
    Oda T; Oda C
    Health Sci Rep; 2023 Jun; 6(6):e1268. PubMed ID: 37275666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward the realization of a better aged society: messages from gerontology and geriatrics.
    Arai H; Ouchi Y; Yokode M; Ito H; Uematsu H; Eto F; Oshima S; Ota K; Saito Y; Sasaki H; Tsubota K; Fukuyama H; Honda Y; Iguchi A; Toba K; Hosoi T; Kita T;
    Geriatr Gerontol Int; 2012 Jan; 12(1):16-22. PubMed ID: 22188494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health Technology Assessment for Cardiovascular Digital Health Technologies and Artificial Intelligence: Why Is It Different?
    Vervoort D; Tam DY; Wijeysundera HC
    Can J Cardiol; 2022 Feb; 38(2):259-266. PubMed ID: 34461229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital Therapeutics in Urology: An Innovative Approach to Patient Care and Management.
    Rodler S; Kowalewski KF; Scheibert H; Bensel M; Stadelmeier LF; Styn A; Belenchon IR; Taratkin M; Puliatti S; Gomez Rivas J; Veccia A; Piazza P; Checcucci E; Michel MS; Stief CG; Cacciamani G;
    Eur Urol Open Sci; 2023 Sep; 55():23-27. PubMed ID: 37593208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining Diversity in Digital Therapeutics Clinical Trials: Descriptive Analysis.
    Adu-Brimpong J; Pugh J; Darko DA; Shieh L
    J Med Internet Res; 2023 Aug; 25():e37447. PubMed ID: 37531157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access and reimbursement pathways for digital health solutions and
    Mantovani A; Leopaldi C; Nighswander CM; Di Bidino R
    Front Med Technol; 2023; 5():1101476. PubMed ID: 36891483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital Therapeutics (DTx) Expand Multimodal Treatment Options for Chronic Low Back Pain: The Nexus of Precision Medicine, Patient Education, and Public Health.
    Rohaj A; Bulaj G
    Healthcare (Basel); 2023 May; 11(10):. PubMed ID: 37239755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriate controls for digital therapeutic clinical trials: A narrative review of control conditions in clinical trials of digital therapeutics (DTx) deploying psychosocial, cognitive, or behavioral content.
    Lutz J; Offidani E; Taraboanta L; Lakhan SE; Campellone TR
    Front Digit Health; 2022; 4():823977. PubMed ID: 36060538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing face of healthcare: digital therapeutics in the management of diabetes.
    Ramakrishnan P; Yan K; Balijepalli C; Druyts E
    Curr Med Res Opin; 2021 Dec; 37(12):2089-2091. PubMed ID: 34511002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.